Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines

Clinical and Vaccine Immunology

Volumn 21, Issue 3, 2014, Pages 453-455

  Kolibab, K ^a,b   Yang, A ^a   Parra, M ^a   Derrick, S C ^a   Morris, S L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; PROTEIN E6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; BACTERIUM DETECTION; CFU COUNTING; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; IN VITRO STUDY; INTERMETHOD COMPARISON; LIQUID CULTURE; MGIT LIQUID CULTURE SYSTEM; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARAMETERS; PRIORITY JOURNAL; TIME TO DETECTION;

ANIMALS; AUTOMATION, LABORATORY; BACTERIOLOGICAL TECHNIQUES; COLONY COUNT, MICROBIAL; HUMANS; MICE; MYCOBACTERIUM TUBERCULOSIS; TIME FACTORS; TUBERCULOSIS;

EID: 84896776558     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00742-13     Document Type: Article

References (20)

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. 1994. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271:698-702. (Pubitemid 24061706)
2. Fine PE. 2001. BCG: the challenge continues. Scand. J. Infect. Dis. 33:243-245. http://dx.doi.org/10.1080/003655401300077144. (Pubitemid 32366645)
3. World Health Organization. 2012. Global tuberculosis report. World Health Organization, Geneva, Switzerland.
4. Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H, the MVA85A 020 Trial Study Team. 2013. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomized, placebo-controlled phase 2b trial. Lancet 381: 1021-1028. http://dx.doi.org/10. 1016/S0140-6736(13)60177-4.
5. Orme IM. 2006. Preclinical testing of new vaccines against tuberculosis: a comprehensive review. Vaccine 9:2-19. http://dx.doi.org/10.1016/vaccine.2005. 07.078. (Pubitemid 41721096)
6. Pheiffer C, Carroll NM, Beyers N, Donald P, Duncan K, Uys P, van Helden P. 2008. Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting. Int. J. Tuberc. Lung Dis. 12:792-798. (Pubitemid 351976711)
7. Wayne LG. 1994. Cultivation of Mycobacterium tuberculosis for research purposes, p 73-83. In Bloom BR (ed), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, DC.
8. Epstein MD, Schluger NW, Davidow AL, Bonk S, Rom WN, Hanna B. 1998. Time to detection of Mycobacterium tuberculosis in sputum cultures correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 113:379-386. (Pubitemid 28110014)
9. Bark CM, Okwera A, Joloba ML, Thiel BA, Nakibali JG, Debanne SM, Boom WH, Eisenach KD, Johnson JL. 2011. Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures. Tuberculosis 91:257-259. http://dx.doi.org/10.1016/j.tube.2011.01.004.
10. Koh WJ, Ko Y, Kim CK, Park KS, Lee NY. 2012. Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system. Ann. Lab. Med. 32:264-269. http://dx.doi.org/10.3343/alm.2012.32.4.264.
11. Duque A, Lin SY, Desmond E, Rienthong S, Rienthong D, Boonin C. 2013. Evaluation of the BD Bactec MGIT 320 for detection of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 51:3403-3405. http://dx.doi.org/10.1128/JCM.01357-13.
12. Shin SJ, Han JH, Manning EJB, Collins MT. 2007. Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system. J. Clin. Microbiol. 45:1941-1948. http://dx.doi.org/10.1128/JCM. 0216-06. (Pubitemid 46933930)
13. Giampaglia CM, Martins MC, Vieria GB, Vinhas SA, Telles MA, Palaci M, Marsico AG, Hadad DJ, Mello FC, Fonseca Lde S, Kritski A. 2007. Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 11:986-991. (Pubitemid 47425025)
14. Rusch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S. 2006. Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J. Clin. Microbiol. 44:688-692. http://dx.doi.org/10. 1128/JCM.44.3.688-692.2006.
15. Lin SY, Desmond E, Bonato D, Gross W, Siddiqi S. 2009. Multicenter evaluation of Bactec 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 47:3630-3644. http://dx.doi.org/10.1128/JCM.00803-09.
16. Derrick SC, Yang AL, Morris SL. 2004. A polyvalent DNA vaccine expressing expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23:780-788. http://dx.doi.org/10.1016/j.vaccine.2004.07.036. (Pubitemid 39473176)
17. Parra M, Yang AL, Lim J, Kolibab K, Derrick S, Cadieux N, Perera LP, Jacobs WR, Brennan M, Morris SL. 2009. Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clin. Vaccine Immunol. 16:1025-1032. http://dx.doi.org/10.1128/ CVI.00067-09.
18. Kolibab K, Parra M, Yang AL, Perera LP, Derrick SC, Morris SL. 2009. A practical in vitro growth inhibition assay for the evaluation of TB vaccines. Vaccine 28:317-322. http://dx.doi.org/10.1016/j.vaccine.2009.10.047.
19. Marsay L, Matsumiya M, Tanner R, Poyntz H, Griffiths KL, Stylianou E, Marsh PD, Williams A, Sharpe S, Fletcher H, McShane H. 2013. Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb). Tuberculosis 93: 551-557. http://dx.doi.org/10.1016/j.tube.2013.04.007.
20. Derrick SC, Dao D, Yang A, Kolibab K, Jacobs WR, Morris SL. 2012. Formulation of a mmaA4 gene deletion mutant of Mycobacterium bovis BCG in cationic liposomes significantly enhances protection against tuberculosis. PLoS One 7(3):e32959. http://dx.doi.org/10.1037/journal.pone.0032959.